IDO1 and neoplasm: Moreover, researchers have demonstrated that RT caused significant reductions in IDO-1 activity during therapy, but increased significantly post-RT, suggesting that IDO-1 activity may be suppressed by anti-tumor immunity in some patients as early as 2 weeks after starting RT.